Cannabinoid receptor 1 and 2 (CB1 and CB2) are G-protein-coupled receptors involved in neurogenic and inflammatory pain and itch, and their agonism showed antipruritic effects at both the central and peripheral levels, in systemic and dermatologic diseases, as well as AD and ACD. The gene discussed is CNR1; the disease is granular corneal dystrophy type II.